A Description of Bacteria in the Mouths of Patients With Severe Aplastic Anemia
A Description of the Oral Microbiome of Patients With Severe Aplastic Anemia
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
This observational or N/A phase trial investigates Severe Aplastic Anemia (SAA) and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 14 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
-
Dec 2019 — Jan 2020 [monthly]
Completed
▶ Show 9 earlier versions
-
Nov 2019 — Dec 2019 [monthly]
Completed
-
Oct 2019 — Nov 2019 [monthly]
Completed
-
Jan 2019 — Oct 2019 [monthly]
Completed
-
Sep 2018 — Jan 2019 [monthly]
Completed
-
Aug 2018 — Sep 2018 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
-
Jun 2018 — Jul 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health Clinical Center (CC)
For direct contact, visit the study record on ClinicalTrials.gov .